Liposomal Doxorubicin Market is Expected to Reach US$ 2,367.5 Million by 2034, Rising at a 6.3% CAGR | Future Market Insights Inc.
03 juil. 2024 08h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, July 03, 2024 (GLOBE NEWSWIRE) -- The liposomal doxorubicin market is estimated to be worth USD 1,281.3 Million in 2024 and is projected to be valued at USD 2,367.5 Million in 2034....